On crushing of deutetrabenazine tablets
- PMID: 33821933
- PMCID: PMC8404741
- DOI: 10.1093/ajhp/zxab130
On crushing of deutetrabenazine tablets
Keywords: Austedo; chorea; crushing; deutetrabenazine; tardive dyskinesia.
Comment in
-
Crushing of deutetrabenazine tablets limited to individual case.Am J Health Syst Pharm. 2021 Aug 30;78(17):1552-1553. doi: 10.1093/ajhp/zxab128. Am J Health Syst Pharm. 2021. PMID: 33765151 No abstract available.
Comment on
-
Crushing deutetrabenazine for treatment of tardive dyskinesia in a patient with severe orofacial symptoms: A case report.Am J Health Syst Pharm. 2020 Sep 4;77(18):1477-1481. doi: 10.1093/ajhp/zxaa205. Am J Health Syst Pharm. 2020. PMID: 32761113
References
-
- Wietholter JP, Sizemore J, Piechowski K. Crushing deutetrabenazine for treatment of tardive dyskinesia in a patient with severe orofacial symptoms: a case report. Am J Health-Syst Pharm. 2020;77(18):1477-1481. - PubMed
-
- Austedo. Package insert.Teva Pharmaceuticals USA, Inc.; revised December 2020. https://www.austedo.com/globalassets/austedo/prescribing-information.pdf
-
- Center for Drug Evaluation and Research, US Food and Drug Administration. Application number 208082-Orig1s000. Chemistry review. Electrically signed March 2, 2017. Accessed December 17, 2020. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208082Orig1s000C...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
